I Just Want to Be a Quiet Top Student

Shen Qi pointed to the production line and said: "Our factory's market share in Liyuexi is good, but the domestic total of this market is only a few hundred million RMB. My idea is to transform the production line in Liyuexi into LPJK1 production line. That’s a lot less money than rebuilding a production line.”

"So LPJK1 will definitely pass the third phase of clinical trials?" Lao Yan asked.

"I don't dare to be complacent, but I have great confidence."

Shen Qi gave a determined look, and said: "The animal experiment of LPJK1 is finished, and it will take a certain amount of time from now to the completion of the clinical trial. I can't guarantee that LPJK1 will be approved and launched successfully, I can only say , there is hope. Lao Yan, my dad doesn’t know much about technology, so it’s still up to you and Lao Cheng. You can make a research plan for the project of Liyuexi production line transformation. Once LPJK1 is done, You immediately start the production line transformation."

Lao Yan looked at Lao Shen and Shen Qi, and asked: "In terms of technology, Lao Cheng and I should be able to handle it. I don't understand sales, so I just ask, will Li Yuexi not produce or sell in the future?"

Liyuexi (midazolam injection) is an intravenous anesthetic widely used in various operations.

Although it is widely used, as Shen Qi said, the total annual sales of Liyuexi in China is only a few hundred million yuan.

Compared with the people who take medicine all year round, the people who undergo surgery are after all a minority. How many operations can a person have in his lifetime?

The fact that the total market share is not high is one thing, but Shen Qi's heart disease is another.

Obaiqi Pharmaceuticals does not own any patents of Liyuexi, they only have the domestic production rights of Liyuexi, and they are not the only domestic pharmaceutical factory producing Yuexi.

This is Shen Qi's heart disease.

For a scientist who is accustomed to being original and owning patent rights, Shen Qi is very reluctant to let his father's factory produce and sell a product that is not original and has no patent rights.

To put it bluntly, isn't this kind of thing like working with others as an OEM or an agent?

The dignified Shen Qi's father is going to work with someone else as an agent?

Shen Qi was not happy.

A few years ago, Lao Shen had no choice but to rely on Li Yuexi to barely maintain the normal operation of the factory when he acquired Oubeqi Pharmaceutical.

With Shen Qi's laboratory's original drug Kangshuen on the market, Obaiqi Pharmaceutical is not what it used to be.

Intellectual property rights determine the initiative of an enterprise. Enterprises without independent intellectual property rights will eventually have a guilty conscience.

Not only guilty, but also possibly perishing.

Tigers and wolves outside have used intellectual property rights and core technologies to embarrass Chinese companies more than once. There are too many such things happening.

We don't want to fight, but we are not afraid of fighting, and we have to fight when necessary.

Hit, you can hit.

But in order to win, we must master independent intellectual property rights and core technologies, the more the better, the more the better.

This is true from the country to the enterprise, from the laboratory to the industrial site.

Old Shen quickly gave his opinion: "According to what Shen Qi said, we will not be able to produce Yuexi in the future, and transform the production line of Liyuexi into an original drug production line, just do it. Teacher Yan, thank you for your hard work."

"OK, I understand!" After all, Lao Yan has a master's degree in science from Yanda University, and he is very aware of the importance of independent intellectual property rights and core technologies.

Just like that, Li Yuexi's fate in Obaiqi Pharmaceutical was decided.

Liyuexi, a second-class psychotropic drug, is strictly controlled by the state, and production approval is difficult to obtain.

Obaiqi Pharmaceutical has the domestic production approval of Liyuexi, which is very valuable.

It's a pity to just abolish an extremely rare approval document like this.

But in Shen Qi's view, intellectual property rights are above all else, and production approvals without independent intellectual property rights are bubbles and falsehoods.

Shen Qi, Lao Shen, and Lao Yan inspected the Liyuexi production line. If they really want to transform this production line into an LPJK1 production line, the amount of work is not small and it will cost a lot of money.

Who pays for this money? Of course it is old Shen Chu.

Obaiqi Pharmaceuticals currently mainly relies on Conshuen, a diabetes drug, for profit. This drug is the most important asset of the pharmaceutical company. To support medicine with medicine, one medicine supports a factory.

"Boss Shen, then I'll arrange manpower and study the plan for the transformation of the Liyue West production line?" Lao Yan asked for instructions.

Shen Qi smiled: "Don't worry, Lao Yan, today is the twenty-sixth day of the twelfth lunar month, the day after tomorrow the whole factory will be on holiday, and it won't be too late to study after the new year starts. Lao Yan, on the twenty-ninth day of the twelfth lunar month, you, Lao Cheng and Let's fly to the capital together as a family of three. Don't you miss your beautiful wife in the capital alone?"

"Of course the concern is the concern. Okay, on the twenty-ninth day of the twelfth lunar month, let's go together. Two bosses, you father and son are chatting alone. I'll go back to the technical department to check the information." Lao Yan then left, letting Shen Qi father and son get along alone.

"Go to Kang Shuen's production workshop and have a look." Shen Qi said.

"Go, over there." Old Shen led Shen Qi towards another workshop, and he said as he walked, "Kangshuen is the lifeblood of our factory. Some foreign pharmaceutical companies have moved their minds and want to buy Kangshuen."

Shen Qi nodded and said: "I know this, they even looked for me."

Old Shen suddenly became excited: "The British GLK company offered 700 million pounds to buy Conshorn, and I scolded them back. The British are too bad, they only want 700 million pounds to get Conshorn? Dream on, British guy!"

Shen Qi shook his head and said, "The 700 million pounds must not be sold to them. Are these British guys mentally retarded when they treat us as father and son?"

Old Shen: "Plus 700 million pounds plus a zero, I might consider it."

Shen Qi showed an incredulous expression: "7 billion pounds? Dad, are you crazy?"

Old Shen explained: "I know that Kang Shuen is your painstaking effort and the original crystallization of your laboratory. I'm just making a hypothesis."

Shen Qi: "No, what I mean is, if you really want to sell Kang Shuen, 7 billion pounds plus zero is the starting price."

"Seven hundred... seventy billion pounds?" Old Shen felt that he was not crazy, but Shen Qi was the one who was crazy.

Shen Qi explained: "Kang Shuen is the original creation of our laboratory, and it is indeed my painstaking effort. If our factory is really short of money, I don't mind you selling Kang Shuen. Dad, let me list some data for you, and you will understand Why Conshorn is worth more than £70 billion."

"Diabetes is a global disease. According to last year's statistics, diabetes consumption accounted for 12% of global medical expenses, and the amount was 778.2 billion U.S. dollars. Yes, you heard it right. Diabetics around the world spend nearly 800 billion U.S. dollars a year on medical expenses. Treat the disease, and the number will continue to rise."

"GLK offers you 700 million pounds to acquire all the patents of Conshin, as well as the global production rights and sales rights. Dad, you can say to them: go to hell."

"Let's just talk about the GLK company. They used to have a global best-selling hypoglycemic drug—Avandia. This Avandia is amazing. In a few years ago, the global sales reached billions of dollars."

"Later, the FDA issued a warning that Avandia's side effects caused cardiovascular disease. Avandia was hit hard, and global sales plummeted. I studied this case in detail. In fact, GLK was quite wronged. Avandia was not blamed by the FDA. It’s so unbearable. A few years ago, the FDA fully lifted the ban on Avandia, but at this time the hypoglycemic drug market has been divided by other international pharmaceutical giants, and GLK’s Avandia will never return to its peak sales.”

"The FDA is like this. They would rather kill by mistake than let it go. But objectively speaking, the FDA's review of drugs is indeed the most stringent in the world, not one of them."

"After Avandia went cold, GLK was very eager to get a new diabetes drug, which was at the same level as Avandia's most glorious period. This is why GLK's sales representatives frequently come to you and me, because our Kang Shuen Exactly what they expected.”

"I've said so much, Dad, you understand now, the value positioning of Kang Shuen is to start at least 70 billion pounds. If you want to sell Kang Shuen, I don't care. If you don't buy the old one, don't buy the new one, it will cost 70 billion pounds. Give me one-tenth of the drug, and I can develop ten new drugs. The remaining nine-tenths, I want to do something more meaningful."

Old Shen was silent. After a long time, he took out the platinum boss signature pen and handed the pen to Shen Qi: "Come on, I'll give you the pen, and you will be the boss."

...

...

Ask for monthly tickets and recommended tickets!